Three brand new studies shed light on use of natalizumab in relapsing-remitting multiple sclerosis.
There’s a new app for tracking symptoms of Parkinson disease, Alzheimer and Parkinson diseases may share characteristics with mad cow disease, and a skin test may one day be used to detect both AD and PD.
Highlights of recent findings about multiple sclerosis are summarized in this slide show.
Some patients who take aspirin have the potential for larger, more severe strokes. Highlights of the latest news about stroke are presented in this slide show.
Minimally invasive surgery to remove clots from the brain and other cutting-edge stroke news for neurologists highlighted the research and clinical program at the International Stroke Conference.
The FDA has recently approved a number of drugs for a variety of neurologic disorders, including Parkinson's disease and MS. Here are 8 of the newest.
With promising names like "5-Minute Neurology Consult" and "Neurosurgery Survival Guide" the mobile applications in this top-pick list provide immediate and encyclopedic access to the nuts, bolts, and nuances of neurologic practice.
What happens before the demyelinating lesions of MS appear? Does smoking confer protection against Parkinson disease? How is NMDA receptor-associated disease reversed? Here are 4 fine papers from 2014 that set out to answer these questions.
Here: 5 new things to know about stroke -- its link with perioperative A-fib; the danger of cocaine; rehab possibilities with an Alzheimer drug; reducing stroke risk with potassium; and a potential screen for occult A-fib after cryptogenic stroke.
Five recent studies offer new insights on migraine headaches-- its pathophysiologic underpinnings and various modes of therapy.